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Disease Severity in COVID-19 Breakthrough Cases
Abstract
Background
Vaccine breakthrough is a phenomenon wherein vaccinated individuals become infected with disease
despite adequate protection. During this study period, the Centers for Disease Control (CDC) reported
66.6% of US people have been fully vaccinated. Any measures to improve trust would increase
vaccination rates. This study aims to understand vaccine breakthrough cases in COVID-19 by comparing
their severity to unvaccinated cases. Our objective is to compare disease severity based on the worst
initial vital signs (temperature, respiratory rate, oxygen saturation), length of stay (LOS), and age between
vaccinated and unvaccinated COVID-19 cases.
Methods
We conducted a retrospective cohort study at Berkshire Medical Center between July 15, 2021, through
October 31, 2021. IRB exemption was obtained. Patient records were reviewed for vaccination status, age,
vital signs, and LOS. We used forward and backward logistic regressions to determine significant
variables and odds ratios to quantify the association between them. We then computed two-sample ttests to compare the variables between vaccinated and unvaccinated groups.
Results
There were 151 vaccinated and 141 unvaccinated COVID-19 cases. Using a forward logistic regression
model, we found significant associations between vaccination status, age (p
Discussion
Our results suggest that vaccination may lead to milder disease even against virulent strains such as the
Delta variant. These findings were similar to another study during the Alpha variant peak that
demonstrated that vaccinated patients had less disease severity. Vaccination was associated with a
7.25% higher likelihood of being older, a 66.08% lower likelihood of having a higher temperature, and an
8.73% higher likelihood of having lower SpO2. There were significant differences in age and max Temp
between vaccinated and unvaccinated groups indicating that vaccination may be associated with less
disease severity even in an older population.
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Abstract
Background: Vaccine breakthrough is a phenomenon wherein vaccinated individuals become infected with disease
despite adequate protection. During this study period, the Centers for Disease Control (CDC) reported 66.6% of US
people have been fully vaccinated. Any measures to improve trust would increase vaccination rates. This study aims to
understand vaccine breakthrough cases in COVID-19 by comparing their severity to unvaccinated cases. Our objective is
to compare disease severity based on the worst initial vital signs (temperature, respiratory rate, oxygen saturation),
length of stay (LOS), and age between vaccinated and unvaccinated COVID-19 cases.
Methods: We conducted a retrospective cohort study at Berkshire Medical Center between July 15, 2021, through
October 31, 2021. IRB exemption was obtained. Patient records were reviewed for vaccination status, age, vital signs, and
LOS. We used forward and backward logistic regressions to determine signiﬁcant variables and odds ratios to quantify
the association between them. We then computed two-sample t-tests to compare the variables between vaccinated and
unvaccinated groups.
Results: There were 151 vaccinated and 141 unvaccinated COVID-19 cases. Using a forward logistic regression model,
we found signiﬁcant associations between vaccination status, age (p < 0.005), and max Temp (p < 0.005). Using a
backward logistic regression model, we found signiﬁcant associations between vaccination status, age (p < 0.005), max
Temp (p < 0.005), and min SpO2 (p < 0.031). Odds ratios were 1.0725 (age), 0.6608 (max Temp), and 1.0873 (min SpO2).
Two-sample t-tests showed signiﬁcant differences in age and max Temp between vaccinated and unvaccinated groups
while no signiﬁcant differences were found in LOS, max RR, and min SpO2.
Discussion: Our results suggest that vaccination may lead to milder disease even against virulent strains such as the
Delta variant. These ﬁndings were similar to another study during the Alpha variant peak that demonstrated that
vaccinated patients had less disease severity. Vaccination was associated with a 7.25% higher likelihood of being older, a
66.08% lower likelihood of having a higher temperature, and an 8.73% higher likelihood of having lower SpO2. There
were signiﬁcant differences in age and max Temp between vaccinated and unvaccinated groups indicating that vaccination may be associated with less disease severity even in an older population.
Keywords: COVID-19, Vaccine breakthrough, Delta variant, Vaccine

1. Introduction

C

OVID-19 vaccine breakthrough is a phenomenon wherein vaccinated individuals become
infected with COVID-19. The Centers for Disease
Control (CDC) assures us that this is to be expected
as no vaccine has 100% effectiveness due to microbiologic mutations which have produced COVID-19
variants.1 Furthermore, it is unclear whether vaccine

*

breakthrough patients have better outcomes or are at
risk of spreading COVID-19, leading to the propagation of misinformation regarding vaccine effectiveness. This contributes to overall reduced
vaccination compliance in the public, and accordingly, the CDC reports that only 66.6% of the total
population in the United States eligible for vaccination have been fully vaccinated during this study
period.2 Although many factors may have resulted in
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this suboptimal percentage, vaccine hesitancy due to
lack of conﬁdence in its efﬁcacy is likely among the
most modiﬁable factors. Any measures to improve
vaccine compliance and trust would increase the
likelihood that the remaining unvaccinated population would consider receiving a COVID-19 vaccine
and future vaccination.
The risk of vaccine breakthrough remains a challenging obstacle to the resolution of the pandemic.
Initially, it appeared that the percentage of breakthrough cases amongst the vaccinated was low,
however, the body of research is still growing with
each passing day.2 In a study conducted in early
2021, vaccine breakthrough cases amongst healthcare workers were low (0.03%).3 Although, there was
conﬂicting information regarding the number of
breakthrough cases and the disease severity.3 Nissimov et al. compiled data from 152 breakthrough
cases in multiple hospitals in Israel and found that
64% required hospitalization for severe symptoms
and the mortality rate was 22% suggesting caution
regarding vaccination as a panacea.4 During the
summer of 2021, breakthrough cases increased
exponentially with the emergence of the Delta
variant. A Houston study from September 2021
found the Delta variant had the highest rate of
breakthrough cases compared to all other variants
combined.5 Additionally, in a review of breakthrough cases looking at the severity of symptoms,
46% were asymptomatic and only 26% had severe
disease.6 Although there were studies into symptomology and hospitalization rates, there are insufﬁcient reviews on United States hospitals quantifying
disease severity in vaccine breakthrough cases.
COVID-19 vaccine breakthrough cases present a
challenge to the healthcare system as they create
skepticism on vaccine effectiveness. This study aims
to further the understanding of COVID-19 vaccine
breakthrough cases by comparing their severity to
unvaccinated COVID-19 cases. A large cohort study
from China in 2020 classiﬁed COVID-19 based on
severity of symptoms with mild to moderate disease
representing mild symptoms up to mild pneumonia,
severe disease representing symptoms such as
dyspnea, hypoxia, or more than 50% lung involvement on imaging, and critical disease representing
symptoms such as respiratory failure, shock, or
multiorgan system dysfunction.7 This is the standard utilized by the CDC along with laboratory tests
such as lymphopenia, neutrophilia, elevated serum
alanine aminotransferase and aspartate aminotransferase levels, elevated lactate dehydrogenase,
high C-reactive protein, and high ferritin levels
which are associated with greater illness severity.8
However, these laboratory tests are not routinely
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done on outpatients and individuals with mild disease. We sought to ﬁnd a less invasive and more
readily accessible method to classify disease severity
such as through early vital sign analysis.
Our primary objective was to compare disease
severity based on the worst initial vital signs (temperature, respiratory rate, and oxygen saturation)
between vaccinated and unvaccinated COVID-19
cases. Our secondary objective was to compare the
length of stay (LOS) and age between vaccinated
and unvaccinated COVID-19 positive patients. We
hypothesized that COVID-19 vaccinated patients
that test positive for COVID-19 would have less
severe symptoms than unvaccinated patients.
Secondarily, we hypothesized that COVID-19
vaccinated patients would have shorter LOS than
unvaccinated patients and be older.

2. Methods
We conducted a retrospective cohort study at
Berkshire Medical Center (BMC), Pittsﬁeld MA with
a designated study period between July 15, 2021,
through October 31, 2021 (Fig. 1). IRB exemption
was obtained. The goal of this study was to determine the disease severity and LOS between vaccinated and unvaccinated COVID-19 patients. The
study population was identiﬁed using BMC Medical
Records Department records for Emergency
Department (ED) patients over 18 years old with
International Classiﬁcation of Disease-10 codes for
COVID- 19 as a diagnosis.
Using the electronic medical record, patient records were reviewed for patients' ages to verify inclusion criteria. Inclusion criteria consisted of all
records of patients who were greater than or equal
to 18 years old with a COVID-19 diagnosis. Exclusion criteria consisted of records of patients who
were under 18 years old, those without a vaccination
status recorded in the medical record, and those
missing vital signs data during their LOS. Duplicate
visits for the same COVID-19 diagnosis were treated
as a single visit. The worst vital signs and longest
LOS over the course of all duplicate visits were
recorded. Vaccination status was designated as
vaccinated with a history of at least 1 COVID-19
vaccine administration found in either the immunization records or if the COVID-19 ED triage
screening recorded “vaccinated”. Vaccination status
was designated as unvaccinated if the COVID-19 ED
triage screening recorded “not vaccinated".
Diagnosis of COVID-19 utilized a rapid antigen
test or nucleic acid ampliﬁcation test.
The vital signs reviewed in each patient record
were highest temperature (max Temp) in
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Fig. 1. Study design ﬂowchart.

Fahrenheit (F), highest respiratory rate (max RR) in
breaths per minute, and lowest oxygen saturation
(min SpO2) in percentage. The worst vital sign for
each category during the entire duration of the ED
visit was recorded. ED disposition, hospital LOS in
days, and age were independently recorded. Sameday discharge from the ED was recorded as a value
of zero LOS.
COVID-19 vaccinated and unvaccinated patients
that tested positive for COVID-19 were compared to
determine disease severity. A forward logistic
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regression model which sequentially adds variables
to maximize their signiﬁcance was computed utilizing the following variables (LOS, age, max Temp,
max RR, min SpO2) to determine if the variables
were signiﬁcantly associated with vaccination status.
A backward logistic regression model which
sequentially removes variables to maximize their
signiﬁcance was computed utilizing the same variables to determine which ones remained signiﬁcant
after the removal of the remaining variables. Odds
ratios (OR) and two-sample t-tests were then
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computed on the variables deemed signiﬁcant by
the backward logistic regression model to determine
strength of association and disease severity.

3. Results
During the 3.5-month study period from July 15th,
2021 through October 31st, 2021, 338 COVID-19
encounters were recorded at the BMC ED. 44
duplicate visits where patients came multiple times
for the same COVID-19 diagnosis were removed
leaving 294 cases. There were two cases without
vaccination statuses recorded that were excluded
resulting in 292 encounters. There were two cases
missing temperature as a vital sign which were
excluded for temperature analyses leaving 290 encounters when evaluating temperature. A total of
292 encounters were used for all other analyses. The
number of vaccinated cases was 151, and the number of unvaccinated cases was 141.
LOS ranged from 0 to 40 days cumulatively
(vaccinated and unvaccinated), from 0 to 21 days
(vaccinated), and from 0 to 40 days (unvaccinated).
Age ranged from 18 to 99 years old cumulatively
(vaccinated and unvaccinated), from 20 to 99 years
(vaccinated), and from 18 to 97 (unvaccinated). Max
Temp ranged from 96.0 to 103.4F cumulatively
(vaccinated and unvaccinated), from 96.0 to 103.4F
(vaccinated), and from 96.5 to 103.3F (unvaccinated).
Max RR ranged from 12 to 48 breaths/minute
cumulatively (vaccinated and unvaccinated), from
15 to 48 breaths/min (vaccinated), and from 12 to 48
breaths/min (unvaccinated). Min SpO2 ranged from
70% to 100% cumulatively (vaccinated and unvaccinated), from 70 to 100% (vaccinated), and from 73
to 100% (unvaccinated) (Table 1).
Forward logistic regression model with the
following variables (LOS, age, max Temp, max RR,
min SpO2) yielded statistically signiﬁcant associations between vaccination status, age (p < 0.005),
and max Temp (p < 0.005). The overall worst predictor of vaccination status was max RR (p < 0.797).
Backward logistic regression model with the same
variables and an alpha threshold of 0.1 yielded statistically signiﬁcant associations between vaccination status, age (p < 0.005), max Temp (p < 0.005),
Table 1. Patient cumulative descriptive statistics.
Variable

Mean (M)

SE

SD

Min

Max

LOS (days)
Age (years)
Max Temp (F)
Max RR
(breaths/min)
Min SpO2 (%)

2.213
54.22
99.16
20.58

±0.295
±1.200
±0.0814
±0.290

5.051
20.53
1.391
4.973

0.000
18.00
95.80
12.00

40.00
99.00
103.4
48.00

94.28

±0.347

5.951

70.00

100.0
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and min SpO2 (p < 0.031). The OR for age was
1.0725 (95% CI 1.0534, 1.0920); for max Temp was
0.6608 (95% CI 0.5277, 0.8275); and for min SpO2 was
1.0873 (95% CI 1.0065, 1.1746).
Two-sample t-tests were conducted to explore the
differences between LOS, age, max Temp, max RR,
and min SpO2 in vaccinated and unvaccinated individuals. An alpha value of 0.05 was utilized. Statistically signiﬁcant differences were evident
between the ages of the vaccinated group (M ¼ 63.7,
SD ¼ 19.1) and the unvaccinated group (M ¼ 44.0,
SD ¼ 16.5); t(288) ¼ 9.48, p ¼ 0.005. Signiﬁcant
differences were also found in the max Temp of the
vaccinated group (M ¼ 98.88, SD ¼ 1.27) and the
unvaccinated group (M ¼ 99.47, SD ¼ 1.47);
t(273) ¼ 3.66, p ¼ 0.005. These results suggest that
the vaccinated individuals tended to be older and
had lower temperatures than unvaccinated individuals. No differences were seen in the LOS
when comparing the vaccinated group (M ¼ 1.98,
SD ¼ 3.47) and the unvaccinated group (M ¼ 2.49,
SD ¼ 6.35); t(211) ¼ 0.85, p ¼ 0.399. No signiﬁcant
differences were observed in the max RR between
the vaccinated group (M ¼ 20.68, SD ¼ 4.80) and the
unvaccinated group (M ¼ 20.48, SD ¼ 5.20);
t(283) ¼ 0.34, p ¼ 0.734. No differences were
detected in the min SpO2 between the vaccinated
group (M ¼ 94.38, SD ¼ 3.71) and the unvaccinated
group (M ¼ 94.69, SD ¼ 4.19); t(279) ¼ 0.67,
p ¼ 0.504. These ﬁndings indicate that vaccination
was not associated with a shorter length of stay,
lower respiratory rate, or higher SpO2 (Table 2).

4. Discussion
In this retrospective cohort study, we found that
COVID-19 vaccination status was associated with
the variables of age, temperature, and SpO2.
Vaccination was associated with a 7.25% higher
likelihood of being older (OR 1.0725, 95% CI 1.0534,
1.0920), a 66.08% lower likelihood of having an increase in temperature (OR 0.6608 95% CI 0.5277,
0.8275), and an 8.73% higher likelihood of having a
lower SpO2 (OR 1.0873, 95% CI 1.0065, 1.1746).
Through two-sample t-tests comparisons of vaccinated and unvaccinated individuals, we found signiﬁcant differences in age (19.72 years, 95% CI
-23.83, 15.64, p < 0.005) and max Temp (0.591 degrees F, 95% CI 0.273, 0.909, p < 0.005) and no signiﬁcant differences in LOS (0.513 days, 95% CI
-0.683, 1.709, p < 0.399), max RR (0.200 breaths/
min, 95% CI -1.354, 0.955, p < 0.734), min SpO2
(0.310%, 95% CI -0.603, 1.224, p < 0.504).
We were able to satisfy our hypothesis that being
vaccinated was associated with increasing age and
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Table 2. Patient vaccinated and unvaccinated descriptive statistics.
Variable

LOS (days)
Age (years)
Max Temp (F)
Max RR
(breaths/min)
Min SpO2 (%)

Vaccinated n ¼ 151

Unvaccinated n ¼ 141

P

6.35
16.5
1.47
5.20

0.85
9.48
3.66
0.34

0.399
0.005
0.005
0.734

4.19

0.67

0.504

SD

M

SD

1.98
63.7
98.88
20.68

3.47
19.1
1.27
4.80

2.49
44.0
99.47
20.48

94.38

3.71

94.69

lower temperature. These results indicate that
vaccination may be associated with less disease
severity as indicated by lower temperature even in
an older population. However, we were unable to
support our hypothesis that being vaccinated was
associated with a shorter length of hospital stay,
lower RR, and higher SpO2. Although there was a
signiﬁcant difference in temperature between both
groups, the averages of both groups remained in the
normal range for temperature and did not exceed
100.4 degrees F. The vaccinated group (n ¼ 25) had a
lower number of individuals with a temperature
over 100.4 degrees F than the unvaccinated group
(n ¼ 32).
During the study period, the most dominant
COVID-19 variant in the United States was the
Delta variant (B.1.617.2), which had higher virulence
and infectivity even in fully vaccinated individuals.9
These results, which highlight data during the peak
of the Delta variant's lifecycle, show that vaccination
was associated with a milder form of the disease.
However, both groups had a similar LOS suggesting
the variant's morbidity was unaffected by vaccination. RR and SpO2 were also similar among groups
suggesting that these variables may not be useful in
characterizing disease severity, supporting the
CDC's caution against pulse oximetry in disease
severity characterization with darker skinned populations.8 Nevertheless, these ﬁndings were supported by a study conducted at the Yale New Haven
Health System that demonstrated that fully vaccinated patients had less disease severity during the
peak of the Alpha variant (B.1.1.7).6,9 Although
vaccines are generally associated with less disease
severity, research during the peak of the Delta
variant showed decreased vaccine efﬁcacy and
higher vaccine breakthrough due to immune
evasion mechanisms when compared to the Alpha
variant.10

5. Limitations and future directions
Limitations of this study include the parameters
we chose to represent disease severity. For
example, a possible explanation for no observed
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t-test

M

signiﬁcant differences in respiratory rate and SpO2
in vaccinated and unvaccinated groups may be due
to changes in these vital signs being observed later
in the disease course. Other comorbid conditions
may have also confounded the vital signs and LOS
in such a way that cannot be isolated without more
restrictive study exclusions such as limiting subjects to healthy individuals or stratifying groups by
certain preexisting disease groups such as chronic
obstructive pulmonary disease, asthma, and
congestive heart failure. Since the vital sign value
used was the worst presenting sign during the ED
stay and not followed for admitted patients,
recording the worst vital signs throughout the
entire hospital stay may capture a more representative picture of the disease severity. Although
there was a signiﬁcant difference in temperature
between groups, this could be explained by the
differences in age rather than vaccination as the
logistic regression does not prove a causal relationship between vaccination and age or temperature. The ED COVID-19 vaccination screening did
not differentiate between fully vaccinated and single dose vaccination which may have skewed the
ﬁndings as partially vaccinated individuals may
have not mounted an appropriate response to a
breakthrough infection resulting in no signiﬁcant
differences in min SpO2 and Max RR.
This study beneﬁted from the amount and variety
of variables selected. The statistical analysis
methods chosen such as logistic regression
permitted the evaluation of many variables at the
same time and helped explain the interaction between multiple variables. Of the cohort groups,
both vaccinated (n ¼ 151) and unvaccinated patients (n ¼ 141) were similar in size, and the study
period coincided with the onset, peak, and decline
of the Delta variant. This provides a unique
perspective on vaccine efﬁcacy during a highly
virulent strain.
Future studies that record radiographic image
ﬁndings or pulmonary spirometry ﬁndings could
better assess the disease severity. Classiﬁcation of
the variant strain of COVID-19 could also determine
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whether the data was capturing the efﬁcacy of
vaccination against a particular virus subtype in
vivo. A larger study with age matched individuals
could better determine whether vaccination had a
causal effect on lowering temperature in breakthrough cases.

6. Conclusion
In conclusion, we found that during the study
period of July 15th, 2021 through October 31st, 2021,
COVID-19 vaccination was associated with less
disease severity as shown by lower temperature and
older age in COVID-19 breakthrough cases when
compared to unvaccinated individuals. Hospital
length of stay, respiratory rate, and SpO2 did not
differ signiﬁcantly between vaccinated and unvaccinated groups. Vaccination was associated with a
7.25% higher likelihood of being older, a 66.08% less
likelihood of having an increase in temperature, and
an 8.73% higher likelihood of having a lower SpO2
while evaluating odds ratios in isolation.
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